+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Bulk, Dosage), By Type, By Route of Administration, By End User, By Region and Competition

  • PDF Icon

    Report

  • 119 Pages
  • March 2023
  • Region: Global
  • TechSci Research
  • ID: 5768459
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global penicillin market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the high prevalence of infectious diseases such as lower respiratory infections, malaria, and tuberculosis, among others. In 2020, Africa had the highest prevalence of tuberculosis incidence per 100 000 population. The incidence rate was about 220. Similarly, the Americas reported some 29 new cases of tuberculosis per 100,000 inhabitants. Additionally, growing initiatives and investments by government organizations and pharmaceutical & biotechnology companies across the globe for developing novel antibiotics have significantly increased the demand for penicillin worldwide. Additionally, the growing adoption of new drugs in the healthcare sector has significantly increased, thereby supporting the growth of global penicillin market. Besides, increasing awareness about novel treatments will further increase the demand for penicillin in the coming years, thereby supporting market growth.

Growing Prevalence of Various Types of Infections

Every day the frequency of bacterial infections is increasing. The main reason for increasing bacterial infection is not maintaining proper health, not washing hands before eating or cooking, sneezing without covering, and poor sanitation and hygiene practices. This has significantly increased the demand for antibiotics, thereby creating lucrative growth opportunities for the penicillin market during the forecast period. In 2021, the daily defined dose of antibiotics consumption in Italy was around 13 per 1,000 inhabitants. Similarly, in low and middle-income countries, public transport is the main source of communication, and most of the spread of bacterial infections is being witnessed due to the use of public transport, thereby increasing the demand for antibiotics and creating opportunities for the growth of the penicillin market.

Expanding Research & Development Activities

The growing incidence of antibiotic resistance in bacteria and the increasing prevalence of various communicable bacterial infections have made biotechnology and pharmaceutical companies focus on developing new and advanced therapies and products. This, in turn, is expected to create new prospects for the growth of the penicillin market. According to clinicaltrials.gov, there are around 93 clinical trials related to penicillin that are under different phases. Similarly, betterment in the new drug approval process is expected to boost market growth over the years. In 2020, Merck received an acceptance for a review of a supplemental new drug application from the U.S. FDA for RECARBRIO intended for HABP/VABP. The growing burden of infectious diseases is compelling government and non-government organizations to invest in research and development activities that will further boost the development of novel antibiotics and create new policies for the development of new drugs.

Market Segmentation

The global penicillin market can be segmented by product, type, route of administration, end-user, and by region. Based on the product, the market can be divided into Bulk and Dosage. Based on type, the market can be segmented into Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, and Others. Based on the route of administration, the market can be differentiated into Oral, Intramuscular, and Intravenous. Based on end users, the market can be grouped into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutions. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among the different countries, the United States dominated the global penicillin market on account of the increasing prevalence of infectious in the country. According to the Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases is around 7.2 million.

Recent Development

  • In August 2022, PAION AG launched XERAVA (eravacycline), in Germany, for the treatment of complicated intra-abdominal infections (cIAI) in adults.
  • In October 2021, the Cephalosporin antibiotics branch of GSK was purchased by Novartis. It is currently the exclusive owner of three well-known brands in more than 100 markets, establishing its position as the top manufacturer of antibiotics across the globe.

Market Players

Astellas Pharma Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Merck Co. & Inc., F.Hoffmann-La Roche Ltd., Toyama Chemical Co., Ltd., Sanofi Aventis SA, MiddleBrook Pharmaceuticals, Inc., Gilead Sciences Inc. are some of the leading players operating in the Global Penicillin Market.

Report Scope:

In this report, global penicillin market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Penicillin Market, By Product:

  • Bulk
  • Dosage

Penicillin Market, By Type:

  • Aminopenicillin
  • Antipseudomonal Penicillin
  • Beta Lactamase Inhibitor
  • Others

Penicillin Market, By Route of Administration:

  • Oral
  • Intramuscular
  • Intravenous

Penicillin Market, By Route of End User:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions

Penicillin Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Global Penicillin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Product (Bulk, Dosage)
6.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)
6.2.3. By Route of Administration (Oral, Intramuscular, Intravenous)
6.2.4. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)
6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.6. By Company (2022)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7. North America Penicillin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Penicillin Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By End User
7.3.2. Canada Penicillin Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By End User
7.3.3. Mexico Penicillin Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By End User
8. Europe Penicillin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Penicillin Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By End User
8.3.2. Germany Penicillin Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By End User
8.3.3. United Kingdom Penicillin Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By End User
8.3.4. Italy Penicillin Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By End User
8.3.5. Spain Penicillin Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By End User
9. Asia-Pacific Penicillin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Type
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Penicillin Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By End User
9.3.2. India Penicillin Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By End User
9.3.3. Japan Penicillin Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By End User
9.3.4. South Korea Penicillin Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value & Volume
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Type
9.3.4.2.3. By Route of Administration
9.3.4.2.4. By End User
9.3.5. Australia Penicillin Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value & Volume
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Type
9.3.5.2.3. By Route of Administration
9.3.5.2.4. By End User
10. South America Penicillin Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Penicillin Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By End User
10.3.2. Argentina Penicillin Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By End User
10.3.3. Colombia Penicillin Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By End User
11. Middle East and Africa Penicillin Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Type
11.2.3. By Route of Administration
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Penicillin Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Type
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Penicillin Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Type
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By End User
11.3.3. UAE Penicillin Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Type
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.1.1. Growing Prevalence of Infectious Diseases
12.1.2. Rise in Research & Development Activities
12.1.3. Supportive Government Policies & Initiatives
12.2. Challenges
12.2.1. Development of Antibacterial Resistance
12.2.2. Stringent Regulatory Scenario
13. Market Trends & Developments
13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches
14. Global Penicillin Market: SWOT Analysis
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.5.1. Astellas Pharma Inc.
15.5.2. Novartis International AG
15.5.3. GlaxoSmithKline plc
15.5.4. Pfizer Inc.
15.5.5. Merck Co. & Inc.
15.5.6. F.Hoffmann-La Roche Ltd.
15.5.7. Toyama Chemical Co., Ltd.
15.5.8. Sanofi Aventis SA
15.5.9. MiddleBrook Pharmaceuticals, Inc.
15.5.10. Gilead Sciences Inc.
16. Strategic Recommendations

Companies Mentioned

  • Astellas Pharma Inc.
  • Novartis International AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Merck Co. & Inc.
  • F.Hoffmann-La Roche Ltd.
  • Toyama Chemical Co., Ltd.
  • Sanofi Aventis SA
  • MiddleBrook Pharmaceuticals, Inc.
  • Gilead Sciences Inc.

Related Topics

Related Reports

Penicillin-Binding Proteins (PBPs) Inhibitor - Pipeline Insight, 2024 - Product Image

Penicillin-Binding Proteins (PBPs) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Penicillin G Potassium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Penicillin G Potassium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 83 Pages
  • Global
From
Penicillin-Binding Proteins - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Penicillin-Binding Proteins - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Penicillin G N-ethylpiperidine salt (CAS 39879-63-5) Global Market Research Report 2024 - Product Image

Penicillin G N-ethylpiperidine salt (CAS 39879-63-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Penicillin Market 2024-2028 - Product Image

Penicillin Market 2024-2028

  • Report
  • 165 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.